Digital Magazine

Schreiner MediPharm Introducing Label + Cap Combination

BLAUVELT, NY | Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, will introduce a new label + cap combination anti-counterfeiting solution to the US market at INTERPHEX NYC 2015 Booth #1053, April 21-23 at the Jacob K. Javits Center. The company’s Flexi-Cap features a first-opening indication security solution that prevents the illegal reuse of medicine containers under the guise of being unopened, original products.

Flexi-Cap comprises a label combined with a cap—a capping similar to the cover for wine bottles but adapted to the specific requirements of the pharmaceutical industry. The result is clear and irreversible indication that a primary container has been opened.

Flexi-Cap works as follows: The film cap is positioned over the closed container. Then, the label is applied without covering the peel-open tab of the opening strip. Once the strip is opened, the bottom part of the cap, together with the label, remains attached to the container. Attempting to remove the rest of the cap destroys the label, eliminating the possibility of unnoticed illegal reuse.

Flexi-Cap enables flexible use with different container types, forms, and sizes. In contrast to shrink-wrap solutions, the label construction is applied without using heat, making the solution viable for temperature-sensitive medicines. The pharmaceutical manufacturer's label and brand design remain unchanged, due to the combination of label and cap. In addition, the top of the cap allows space for bar code printing or NFC chip integration for electronic tracking.

Flexi-Cap can be easily integrated into existing production processes. By adding extra security features such as holographs, color-shifting inks, void effects, or the machine-readable LaserSecure technology, manufacturers can increase even further the hurdles for would-be counterfeiters.

“Flexi-Cap’s innovative security concept allows for flexible, customized implementation of a highly effective anti-counterfeiting tactic,” said Gene Dul, president of Schreiner MediPharm U.S. “It accomplishes this by yielding plainly apparent physical and visual evidence of a container’s use – ones that vastly diminish the potential for illicit market reintroduction.”

This email address is being protected from spambots. You need JavaScript enabled to view it.

Subscribe to PFFC's EClips Newsletter